NCT05159960View on ClinicalTrials.gov

Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial

NAEnrolling by invitationINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Glaucoma, Open-AnglePseudoexfoliation GlaucomaOcular Hypertension
Interventions
PROCEDURE

SLT

A drop of Pilocarpine 4% is administered to the eye 20 minutes before SLT. Immediately before SLT a drop of Tetracaine hydrochloride 1% is administered. Selective laser trabeculoplasty is conducted through a Latina lens, in a fashion determined by randomization to a study arm (see description).

Trial Locations (2)

45153

Department of Ophthalmology, NU Hospital Group, Uddevalla

54142

Department of Ophthalmology, Skaraborg Hospital, Skövde

All Listed Sponsors
collaborator

Göteborg University

OTHER

lead

Vastra Gotaland Region

OTHER_GOV